Pharmacology
-
Erin Calipari receives ACNP’s Daniel H. Efron Research Award
With novel insights in understanding and treating substance use disorder that have redirected neuropsychopharmacological dogma, Erin Calipari receives award from the American College of Neuropsychopharmacology. Read MoreDec. 1, 2025
-
Niswender receives Nicholas Hobbs Discovery Award to test a new therapeutic approach for Rett Syndrome
Niswender’s project seeks to understand why levels of mGlu7 are reduced in Rett syndrome and to test a new therapeutic approach using DNA molecules to restore those levels. This work could pave the way for new drug therapies to address symptoms of Rett syndrome and related disorders, while also advancing advocacy and visibility for these conditions in the scientific community. Read MoreNov. 20, 2025
-
Six Basic Sciences faculty among this year’s ‘highly cited’ researchers
They are among 6,868 scientists worldwide whose papers rank in the top 1% by citations for their fields of research and publication year in the Web of Science Core Collection over the past 11 years. Read MoreNov. 20, 2025
-
Pharmacologist Shan Meltzer receives Edward Mallinckrodt, Jr. Foundation Award to uncover how our sense of touch and pain develops
Shan Meltzer has been awarded a prestigious Edward Mallinckrodt, Jr. Foundation Award to advance her pioneering research on determining how the body’s sensory circuits form and function. Meltzer’s research could ultimately lead to new ways to rewire and repair sensory circuits to treat somatosensory disorders such as chronic pain, nerve injuries, and spinal cord injuries. Read MoreOct. 23, 2025
-
Vanderbilt scientist tackles key roadblock for AI in drug discovery
Vanderbilt’s Dr. Benjamin P. Brown is improving the way the field of drug discovery creates machine learning algorithms to predict a protein’s interactions with a small molecule. These improvements bring ML closer to fulfilling its potential in the field—something that has not been realized after more than a decade of work. Read MoreOct. 16, 2025
-
Promising new drug combination may help melanoma patients resistant to treatment respond once again to the body’s immune defenses
Vanderbilt researchers led by Ann Richmond have identified a promising drug combination that targets three key pathways in advanced melanoma, potentially restoring the immune response in patients resistant to standard immunotherapy. Although the work is preclinical, the use of drugs already in clinical trials for other conditions could accelerate testing in humans. Read MoreOct. 15, 2025
-
Prashant Donthamsetti wins prestigious NIH pioneer award to advance addiction research
Prashant Donthamsetti has received a prestigious NIH Director’s Pioneer Award from the National Institute on Drug Abuse. His project will use a new platform called Tag-Guided Drug to uncover how specific dopamine signaling proteins contribute to addiction. This work paves the way for more precise and effective addiction therapies. Read MoreSep. 25, 2025
-
Hayes, Nagarajan, and Costanzo win 2025 Cell Imaging Shared Resource Life Is Beautiful Image Contest
James Hayes, Rekha Nagarajan, and James Costanzo are the winners of the 2025 Cell Imaging Shared Resource Life Is Beautiful image contest. CISR provides researchers with access to state-of-the-art imaging equipment and expert technical support for sophisticated microscopy and analysis of tissue and cellular anatomy and physiology. Read MoreAug. 7, 2025
-
Vanderbilt basic science alum Q&A: Richard Gustin
Richard Gustin, PhD’10, sat down with us to discuss his experience studying basic science and pharmacology at Vanderbilt and how it played a role in his career. Gustin is now a senior director of innovation and strategic initiatives at Neurelis, Inc. Read MoreAug. 5, 2025
-
Celebrating appointments and promotions in the School of Medicine Basic Sciences: April–June 2025
Congratulations to our School of Medicine Basic Sciences members who were promoted or received new appointments between April and June 2025. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read MoreJul. 16, 2025